Abstract
Background
This study aimed to assess the prevalence of complex sleep apnoea (CompSA), defined as central sleep apnoea (CSA) emerging after the initiation of continuous positive airway pressure (CPAP) therapy for obstructive sleep apnoea (OSA), in patients with normal brain natriuretic peptide (BNP) levels, along with assessing the prevalence of CSA persisting in such patients after the onset of CPAP therapy. We hypothesised that the prevalence of CompSA and persistent CSA after CPAP initiation would be low in patients with OSA and normal BNP levels.
Material and methods
Between April 2004 and July 2007, CPAP was initiated for all patients with OSA for two nights using a standardised protocol. The prevalence of CompSA syndrome (CompSAS) and persisting CSA [central apnoea index (CAI) >5/h and apnoea–hypopnoea index (AHI) >15/h with >50% central events during CPAP therapy] was prospectively assessed in patients with normal BNP levels. Patients with CompSAS or persisting CSA upon CPAP treatment received adaptive servoventilation (ASV).
Results
Of 1,776 patients with OSA receiving CPAP, 28 patients (1.57%) had CSA at the time of CPAP therapy and normal BNP levels. Additionally, 10 patients had CompSAS (0.56%) and 18 patients (1.01%) had persisting CSA. In patients with CompSA or persisting CSA, the AHI was significantly lower with CPAP therapy than at the time of diagnosis (34 ± 15/h vs. 47 ± 20/h, p = 0.005). The CAI increased from 10 ± 10/h to 18/h ± 13/h (p = 0.009) upon initiation of CPAP therapy. ASV reduced the AHI to 6 ± 12/h (p < 0.001) during the first night of use.
Conclusion
The prevalence of CompSA or persisting CSA in patients with OSA and normal BNP levels who are receiving CPAP therapy is low (1.57%). ASV is an effective treatment for these patients.
Similar content being viewed by others
References
Thomas RJ, Terzano MG, Parrino L, Weiss JW (2004) Obstructive sleep-disordered breathing with a dominant cyclic alternating pattern—a recognizable polysomnographic variant with practical clinical implications. Sleep 27:229–234
Morgenthaler TI, Kagramanov V, Hanak V, Decker PA (2006) Complex sleep apnea syndrome: is it a unique clinical syndrome? Sleep 29:1203–1209
Xie A, Rutherford R, Rankin F, Wong B, Bradley TD (1995) Hypocapnia and increased ventilator responsiveness in patients with idiopathic central sleep apnea. Am J Respir Crit Care Med 152:1950–1955
Solin P (2000) Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med 162:2194–2200
Philippe C, Stoica-Herman M, Drouot X, Raffestin B, Escourrou P, Hittinger L, Michel PL, Rouault S, d’Ortho MP (2006) Compliance with and efficacy of adaptive servo-ventilation (ASV) versus continuous positive airway pressure (CPAP) in the treatment of Cheyne–Stokes respiration in heart failure over a six month period. Heart 92:337–342
Teschler H, Döhring J, Wang YM, Berthon-Jones M (2001) Adaptive pressure support servo-ventilation. Am J Respir Crit Care Med 164:614–619
Pepperell JC, Maskell NA, Jones DR, Langford-Wiley BA, Crosthwaite N, Stradling JR, Davies RJ (2003) A randomized controlled trial of adaptive ventilation for Cheyne–Stokes breathing in heart failure. Am J Respir Crit Care Med 168:1109–1114
Töpfer V, El-Sebai M, Wessendorf TE, Moaridis I, Teschler H (2004) Adaptive servoventilation bei chronischer Herzinsuffizienz: Wirkung auf Cheyne-Stokes-Atmung und Lebensqualität. Pneumologie 58:28–32
Westhoff M, Arzt M, Litterst P (2010) Influence of adaptive servoventilation on B-type natriuretic peptide in patients with Cheyne–Stokes respiration and mild to moderate systolic and diastolic heart failure. Pneumologie 64:467–473
Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Bethesda, Maryland, U.S. Department of Health, Education, and Welfare Public Health service, National Institutes of Health
AASM (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 22:667–689
McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, Tunstall-Pedoe H, McMurray JJ, Dargie HJ (1998) Biochemical detection of left-ventricular systolic dysfunction. Lancet 351:9–13
Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS (2002) Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recording. Circulation 105:595–601
Steg PG, Joubin L, McCord J, Abraham WT, Hollander JE, Omland T, Mentré F, McCullough PA, Maisel AS (2005) B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea. Chest 128:21–29
Christ M, Sharkova Y, Fenske H, Rostig S, Herzum I, Becker HF, Mueller C, Grimm W (2007) Brain natriuretic peptide for prediction of Cheyne–Stokes respiration in heart failure patients. Int J Cardiol 116:62–69
Banno K, Okamura K, Kryger MH (2006) Adaptive servo-ventilation in patients with idiopathic Cheyne–Stokes breathing. J Clin Sleep Med 2:181–186
Lehman S, Antic NA, Thompson C, Catcheside PG, Mercer J, McEvoy RD (2007) Central sleep apnea on commencement of continuous positive airway pressure in patients with a primary diagnosis of obstructive sleep apnea-hypopnea. J Clin Sleep Med 3:462–466
Kuzniar TJ, Pusalavidyasagar S, Gay PC, Morgenthaler TI (2008) Natural course of complex sleep apnea—a retrospective study. Sleep Breath 12:135–139
Leung RS, Huber MA, Rogge T, Maimon N, Chiu KL, Bradley TD (2005) Association between atrial fibrillation and central sleep apnea. Sleep 28:1543–1546
Mansfield DR, Solin P, Roebuck T, Bergin P, Kaye DM, Naughton MT (2003) The effect of successful heart transplant treatment of heart failure on central sleep apnea. Chest 124:1675–1681
Gilmartin GS, Daly RW, Thomax JR (2005) Recognition and management of complex sleep-disordered breathing. Curr Opin Pulm Med 11:485–493
Issa FG, Sullivan CE (1986) Reversal of central sleep apnea using nasal CPAP. Chest 90:165–171
Eckert DJ, Jordan AS, Merchia P, Malhotra A (2007) Central sleep apnea: pathophysiology and treatment. Chest 131:595–607
Sankri-Tarbichi AG, Rowley JA, Badr MS (2009) Expiratory pharyngeal narrowing during central hypocapnic hypopnea. Am J Respir Crit Care Med 179:313–319
Badr MS, Toiber F, Skatrud JB, Dempsey J (1995) Pharyngeal narrowing/occlusion during central sleep apnea. J Appl Physiol 78:1806–1815
Luo YM, Tang J, Jolley C et al (2009) Distinguishing obstructive from central sleep apnea events. Diaphragm electromyogram and esophageal pressure compared. Chest 135:1133–1141
Javaheri S, Smith J, Chung E (2009) The prevalence and natural history of complex sleep apnea. J Clin Sleep Med 5:205–211
Dernaika T, Tawk M, Nazir S, Younis W, Kinasewitz GT (2007) The significance and outcome of continuous positive airway pressure-related central sleep apnea during split-night sleep studies. Chest 132:81–87
Morgenthaler TI, Gay PC, Gordon N, Brown LK (2007) Adaptive servoventilation versus noninvasive positive pressure ventilation for central, mixed, and complex sleep apnea syndromes. Sleep 30:468–475
Pusalavidyasagar SS, Olson EJ, Gay PC, Morgenthaler TI (2006) Treatment of complex sleep apnea syndrome: a retrospective comparative review. Sleep Med 7:474–479
Allam JS, Olson EJ, Gay PC, Morgenthaler TI (2007) Efficacy of adaptive servoventilation in treatment of complex and central sleep apnea syndromes. Chest 132:1839–1846
Randerath WJ, Galetke W, Rühle KH (2003) Auto-adjusting CPAP based on impedance versus bilevel pressure in difficult-to-treat sleep apnea syndrome: a prospective randomized crossover study. Med Sci Monit 9:CR353–CR358
Zirlik S, Schahin SP, Premm W, Hahn EG, Fuchs FS (2009) Lung volumes and mean apnea duration in obstructive sleep apnea. Respir Physiol Neurobiol 168:303–305
Bitter T, Westerheide N, Faber L, Hering D, Prinz C, Langer C, Horstkotte D, Oldenburg O (2010) Adaptive servoventilation in diastolic heart failure. Eur Respir J 36:385–392
Solin P, Jackson DM, Roebuck T, Naughton MT (2002) Cardiac diastolic function and hypercapnic ventilatory responses in central sleep apnoea. Eur Respir J 20:717–723
Hall MJ, Xie A, Rutherford R, Ando S, Floras JS, Bradley TD (1996) Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med 154:376–381
Arzt M, Schulz M, Schroll S, Budweiser S, Bradley TD, Riegger GA, Pfeifer M (2009) Time course of continuous positive airway pressure effects on central sleep apnoea in patients with chronic heart failure. J Sleep Res 18:20–25
Johnson KG, Johnson DC (2005) Bilevel positive airway pressure worsens central apnoeas during sleep. Chest 128:2141–2150
Conflict of interest
Dr. P. Litterst reports that no significant conflicts of interest exist with any companies/organisations whose products or services are discussed in this article. There was no financial support for the study itself from any company. Michael Westhoff and Michael Arzt have received lecture fees from Respironics and Resmed, Germany; Michael Arzt has received unrestricted grant support from Resmed, Germany and grant support from the German Foundation for Cardiac Research (Deutsche Stiftung für Herzforschung).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Westhoff, M., Arzt, M. & Litterst, P. Prevalence and treatment of central sleep apnoea emerging after initiation of continuous positive airway pressure in patients with obstructive sleep apnoea without evidence of heart failure. Sleep Breath 16, 71–78 (2012). https://doi.org/10.1007/s11325-011-0486-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-011-0486-0